Loading inventors, assignments & file history…
Abstract
The compounds of the following formula: wherein Ar, R and R 1 have the meanings given in the specification. This series of sulfonamido derivatives with a conserved uronamide group at the 5′ position provide superior A3 receptor affinity as well as selectivity. These new adenosine agonists are sulfonamido derivatives N-substituted with aliphatic groups (cyclic or linear) or aromatic radicals.
Claims (2)
1. A compound selected from the group consisting of compounds of the following formulae:
or a pharmaceutically acceptable salt thereof.
Assignments (8)
RELEASE OF SECURITY INTEREST
Recorded Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025738/0132 →
SECURITY AGREEMENT
Recorded May 13, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 025703/0628 →
RELEASE OF SECURITY INTEREST [04/09]
Recorded May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0114 →
RELEASE OF SECURITY INTEREST
Recorded May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →
SECURITY AGREEMENT
Recorded May 1, 2009
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 022619/0803 →
SECURITY AGREEMENT
Recorded Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 30, 2005
From: BRALDI, PIER GIOVANNI; MOORMAN, ALLAN R.; BOREA, PIER A.
To: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
Reel/Frame 016728/0191 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 23, 2005
From: BRALDI, PIER GIOVANNI; MOORMAN, ALLAN R.; BOREA, PIER A.
To: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
Reel/Frame 016723/0216 →